JPRN-UMIN000012412已完成未知
A prospective observational study of structure and visual field age-related progression in normal eye - A prospective observational study of structure and visual field age-related progression in normal eye
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 38
研究概览
简要总结
Age-related changes in the sensitivity of the visual field were not detected in Fovea.There were differences by location, more pronounced in the lower hemifield than in the upper hemifield, and in the central field than in the peripheral field. The older the age, the greater the annual decline tended to be, but this trend was not observed in the periphery. The higher the original sensitivity, the greater the tendency.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Subject who has a disease which considered difficult to perticipate study The investigator, subinvestigator determined that the person is ineligible as study subject
研究者
相似试验
招募中
不适用
The Changes in Functional Visual Acuity and Corneal Epithelium Disorder with Eye Drops in Glaucoma PatientsGlaucomaJPRN-UMIN000020653Okayama University100
已完成
不适用
Study of effects on the retina morphological changes and vision of Aflibercept intravitreal injection in patients with macular edema due to central retinal vein occlusion.For recurrent or persistent macular edema due to central retinal vein occlusion of the following antiJPRN-UMIN000014116agasaki University Hospital30
已完成
不适用
Changes of Visual function and Subjective symptoms before and after cataract operatiocataractJPRN-UMIN000023037Keio university school of medicine750
进行中(未招募)
不适用
A phase IIIb study on the changes in ocular signs, symptoms and conjunctival inflammatory markers in patients with ocular hypertension or open-angle glaucoma switched from preserved latanoprost 0.005% eye drops to preservative free tafluprost 0.0015% eye drops.EUCTR2007-004872-37-DESanten Oy150
进行中(未招募)
不适用
A phase IIIb study on the changes in ocular signs, symptoms and conjunctival inflammatory markers in patients with ocular hypertension or open-angle glaucoma switched from preserved latanoprost 0.005% eye drops to preservative free tafluprost 0.0015% eye drops.EUCTR2007-004872-37-SESanten Oy150
